Arimidex Vs Tamoxifen

Featured Article

The breast cancer medication Arimidex beats tamoxifen when it comes to preventing recurrences of hormone-receptor-positive breast cancer in postmenopausal women, a new study suggests. Researchers say Arimidex improved disease-free survival by 15 percent compared with tamoxifen. And the medication continued to work even three years after stopping therapy.

Read more

More information on "Arimidex Vs Tamoxifen"

From Our Experts

See more SharePosts »

From Our Sources

More on Breast Cancer »